Development of a cysteine responsive chlorinated hemicyanine for image-guided dual phototherapy

Bioorg Chem. 2022 May:122:105725. doi: 10.1016/j.bioorg.2022.105725. Epub 2022 Mar 17.

Abstract

A cysteine (Cys) activatable chlorinated hemicyanine (Cl-Cys) was introduced as a tumour selective image-guided dual phototherapy agent. Cl-Cys exhibited a significant turn on response in its near-IR emission signal and activated its singlet oxygen generation as well as photothermal conversion potentials upon reacting with Cys. The laser irradiation of Cl-Cys induced significant cell death in cancer cells with high Cys level, while it stayed deactivated and non-emissive in a healthy cell line. A profound synergistic PDT/PTT effect was observed at high doses. Remarkably, Cl-Cys marks the first ever example of Cys-responsive small organic-based therapeutic agent and holds a great promise to develop new activity-based photosensitizers for dual phototherapy action.

Keywords: Cancer; Cysteine; Hemicyanine; Photosensitizers; Phototherapy; Theranostics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbocyanines
  • Cell Line, Tumor
  • Cysteine
  • Nanoparticles*
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Phototherapy

Substances

  • Carbocyanines
  • Photosensitizing Agents
  • tetramethylene hemicyanine
  • Cysteine